Literature DB >> 16701948

Association study of the PIN1 gene with Alzheimer's disease.

Jean-Charles Lambert1, Faiza Bensemain, Julien Chapuis, Dominique Cottel, Philippe Amouyel.   

Abstract

Genetic linkage studies indicate evidence for one or more Alzheimer's disease (AD) genes on chromosome 19 independently of the apolipoprotein E gene, a well-characterized AD-risk factor. Recently, the PIN1 gene on chromosome 19p13.2 has been proposed as a candidate gene for AD. Here, we have investigated the potential impact of two promoter polymorphisms (rs2233678 and rs2233679) within this gene on the risk of developing AD. No association of these polymorphisms or haplotypes with the disease was observed in a large French case-control population. Our data suggest that these genetic variants in PIN1 do not make a significant contribution to AD risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16701948     DOI: 10.1016/j.neulet.2006.04.010

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease.

Authors:  Suk Ling Ma; Nelson Leung Sang Tang; Cindy Woon Chi Tam; Victor Wing Cheong Lui; Linda Chiu Wa Lam; Helen Fung Kum Chiu; Jane Ann Driver; Lucia Pastorino; Kun Ping Lu
Journal:  Neurobiol Aging       Date:  2010-06-30       Impact factor: 4.673

2.  Interactome mapping suggests new mechanistic details underlying Alzheimer's disease.

Authors:  Montserrat Soler-López; Andreas Zanzoni; Ricart Lluís; Ulrich Stelzl; Patrick Aloy
Journal:  Genome Res       Date:  2010-12-16       Impact factor: 9.043

Review 3.  Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?

Authors:  Martin Balastik; Jormay Lim; Lucia Pastorino; Kun Ping Lu
Journal:  Biochim Biophys Acta       Date:  2007-01-23

Review 4.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

5.  A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity.

Authors:  Jiachun Lu; Zhibin Hu; Sheng Wei; Li-E Wang; Zhensheng Liu; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

6.  Association studies between common variants in prolyl isomerase Pin1 and the risk for late-onset Alzheimer's disease.

Authors:  Petra Nowotny; Sarah Bertelsen; Anthony L Hinrichs; John S K Kauwe; Kevin Mayo; Sarah Jacquart; John C Morris; Alison Goate
Journal:  Neurosci Lett       Date:  2007-04-13       Impact factor: 3.046

7.  The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger.

Authors:  Chan H Han; Jiachun Lu; Qingyi Wei; Melissa L Bondy; Abenaa M Brewster; Tse-Kuan Yu; Thomas A Buchholz; Banu K Arun; Li-E Wang
Journal:  Breast Cancer Res Treat       Date:  2009-12-24       Impact factor: 4.872

8.  Genetic variation in the tau protein phosphatase-2A pathway is not associated with Alzheimer's disease risk.

Authors:  José L Vázquez-Higuera; Ignacio Mateo; Pascual Sánchez-Juan; Eloy Rodríguez-Rodríguez; Ana Pozueta; Miguel Calero; José L Dobato; Ana Frank-García; Fernando Valdivieso; José Berciano; Maria J Bullido; Onofre Combarros
Journal:  BMC Res Notes       Date:  2011-09-07

9.  Single nucleotide polymorphisms of PIN1 promoter region and cancer risk: evidence from a meta-analysis.

Authors:  Jing-Jing Peng; Dong Wei; Dong Li; Zeng-Qiang Fu; Yong Tan; Tao Xu; Jing-Jun Zhou; Tao Zhang
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  PIN1 gene variants in Alzheimer's disease.

Authors:  Aleksandra Maruszak; Krzysztof Safranow; Katarzyna Gustaw; Beata Kijanowska-Haładyna; Katarzyna Jakubowska; Maria Olszewska; Maria Styczyńska; Mariusz Berdyński; Andrzej Tysarowski; Dariusz Chlubek; Janusz Siedlecki; Maria Barcikowska; Cezary Zekanowski
Journal:  BMC Med Genet       Date:  2009-11-12       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.